The bee genus Caenaugochlora (Hymenoptera, Apoidea) and its constituent subgenera, with new species of Caenaugochlora s.str. from Ecuador

Two new species of Caenaugochlora Michener are described and figured from Ecuador. Caenaugochlora quichua sp. n. and C. bennetti sp. n. are both remarkable for the presence of carinate preoccipital carinae, setose compound eyes, strongly rimmed metabasitibial plate, normally pectinate inner metatibial spur, metapostnotal striae not reaching the apical margin, and the male fourth metasomal sterna with lateral projections. The combination of these features intermingle attributes of the presently recognized subgenera, while others are unique to the genus as a whole. A revised diagnosis is provided for the genus and its two subgenera, with Caenaugochlora s.str. accommodating C. bennetti and C. quichua, and brief comments made regarding the implications of the characters exhibited by the aforementioned species.

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

Objectives: To review and describe studies of the non-psychotomimetic constituent of Cannabis sativa, cannabidiol (CBD), as an anxiolytic drug and discuss its possible mechanisms of action. Method: The articles selected for the review were identified through searches in English,articles, and book chapters were handsearched for additional references. Experimental animal and human studies were included, with no time restraints. Results: Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. like", and "cannabidiol and anxiety". The reference lists of the publications included, review Portuguese, and Spanish in the electronic databases ISI Web of Knowledge, SciELO, PubMed, and PsycINFO, combining the search terms "cannabidiol and anxiolytic", "cannabidiol and anxiolytic-articles, and book chapters were handsearched for additional references. Experimental animal and human studies were included, with no time restraints. Results: Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. Moreover, CBD was shown to reduce anxiety in patients with social anxiety disorder. Conclusion: like", and "cannabidiol and anxiety". The reference lists of the publications included, review Future clinical trials involving patients with different anxiety disorders are warranted, especially of panic disorder, obsessive-compulsive disorder, social anxiety disorder, and post-traumatic stress disorders. The adequate therapeutic window of CBD and the precise mechanisms involved in its anxiolytic action remain to be determined.